Skip to content
OpenCapital
Get started

Viatris VTRS Japan, Australia and New Zealand Segment — Cost of Sales

Similar metrics at other companies

Edwards Lifesciences logo
EWJapan — Cost of Sales
$14.3M+16.3%
NuSkin Enterprises logo
NUSJapan — Cost of Goods Sold
$8.58M-2.0%
Brady Corporation logo
BRCEurope & Australia — Cost of goods sold
$69.99M+9.9%
Apple logo
AAPLJapan — Cost of Sales
$4.27B+18.2%
Preformed Line Products logo
PLPCAsia-Pacific — Cost of products sold
$17.86M+8.9%
NAG
NAGEPharmaceuticals segment — Cost of Sales
$0—

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$18.49B+81.7%
Enterprise value$31.3B+29.5%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%—
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity1×+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept vtrs:CostOfProductAndServiceSoldAdjusted.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's japan, australia and new zealand segment — cost of sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's japan, australia and new zealand segment — cost of sales?
Viatris (VTRS) reported japan, australia and new zealand segment — cost of sales of $174.4M in Q1 2026.
How has Viatris's japan, australia and new zealand segment — cost of sales changed year-over-year?
Viatris's japan, australia and new zealand segment — cost of sales decreased by 1.2% year-over-year, from $176.5M to $174.4M.
What does japan, australia and new zealand segment — cost of sales mean?
This metric includes the direct costs attributable to the production and distribution of pharmaceutical products sold within the Japan, Australia, and New Zealand region. It encompasses raw materials, manufacturing labor, and logistics costs required to bring products to market. Monitoring this helps assess the manufacturing efficiency and supply chain cost structure for this specific geography.